Phytochemicals in the Prevention and Treatment of SARS-CoV-2-Clinical Evidence
The first case of SARS-CoV-2 infection was reported in December 2019. Due to the rapid spread of the disease and the lack of adequate therapy, the use of plants that have a long history in the treatment of viral infections has often been considered. The aim of this paper is to provide a brief review...
Saved in:
Main Authors: | Katarina Bijelić (Author), Maja Hitl (Author), Nebojša Kladar (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SARS‐CoV‐2 and human milk: What is the evidence?
by: Kimberly A. Lackey, et al.
Published: (2020) -
Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences
by: Elena Campione, et al.
Published: (2021) -
SARS-CoV-2 and prematurity. Any evidence of vertical transmission?
by: Elena María Márquez Isidro, et al.
Published: (2021) -
Quercetin in the Prevention and Treatment of Coronavirus Infections: A Focus on SARS-CoV-2
by: Amin Gasmi, et al.
Published: (2022) -
Docking and Dynamics Study of Phytochemicals as Potent Inhibitors against SARS-CoV-2 Main Protease
by: Palla Ramprasad, et al.
Published: (2022)